首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Inaugural Article: A macromolecular delivery vehicle for protein-based vaccines: Acid-degradable protein-loaded microgels
【2h】

Inaugural Article: A macromolecular delivery vehicle for protein-based vaccines: Acid-degradable protein-loaded microgels

机译:就职文章:用于蛋白质疫苗的大分子递送载体:可酸降解的载有蛋白质的微凝胶

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The development of protein-based vaccines remains a major challenge in the fields of immunology and drug delivery. Although numerous protein antigens have been identified that can generate immunity to infectious pathogens, the development of vaccines based on protein antigens has had limited success because of delivery issues. In this article, an acid-sensitive microgel material is synthesized for the development of protein-based vaccines. The chemical design of these microgels is such that they degrade under the mildly acidic conditions found in the phagosomes of antigen-presenting cells (APCs). The rapid cleavage of the microgels leads to phagosomal disruption through a colloid osmotic mechanism, releasing protein antigens into the APC cytoplasm for class I antigen presentation. Ovalbumin was encapsulated in microgel particles, 200–500 nm in diameter, prepared by inverse emulsion polymerization with a synthesized acid-degradable crosslinker. Ovalbumin is released from the acid-degradable microgels in a pH-dependent manner; for example, microgels containing ovalbumin release 80% of their encapsulated proteins after 5 h at pH 5.0, but release only 10% at pH 7.4. APCs that phagocytosed the acid-degradable microgels containing ovalbumin were capable of activating ovalbumin-specific cytoxic T lymphocytes. The acid-degradable microgels developed in this article should therefore find applications as delivery vehicles for vaccines targeted against viruses and tumors, where the activation of cytoxic T lymphocytes is required for the development of immunity.
机译:基于蛋白质的疫苗的开发仍然是免疫学和药物递送领域中的主要挑战。尽管已鉴定出许多蛋白抗原,它们可对传染性病原体产生免疫力,但基于蛋白抗原的疫苗的开发由于投放问题而取得的成功有限。在本文中,合成了一种酸敏感性微凝胶材料,用于开发基于蛋白质的疫苗。这些微凝胶的化学设计应使其在抗原呈递细胞(APC)吞噬体中的弱酸性条件下降解。微凝胶的快速裂解通过胶体渗透机制导致吞噬体破坏,从而将蛋白质抗原释放到APC细胞质中以进行I类抗原呈递。卵白蛋白被包裹在直径200-500 nm的微凝胶颗粒中,通过反相乳液聚合和合成的可酸降解的交联剂制备。卵清蛋白以pH依赖的方式从可酸降解的微凝胶中释放;例如,含有卵清蛋白的微凝胶在pH 5.0下5小时后释放80%的包封蛋白,而在pH 7.4下仅释放10%。吞噬含卵白蛋白的酸可降解微凝胶的APC能够激活卵白蛋白特异的细胞毒性T淋巴细胞。因此,本文开发的可酸降解的微凝胶应找到作为针对病毒和肿瘤的疫苗的递送载体的应用,其中免疫活性的发展需要活化细胞毒性T淋巴细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号